CRWN TOR Week ended 24 Jul 2026

Weekly Investor Report

Crown Capital Partners Inc. · Financial Services · Credit Services

Open interactive chart View report data
Latest close 1.18 CAD
-25.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 57.6% above the Trend Line and sits at 44.8% of its 52-week range. The latest completed week returned -25.8%, after a 7.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.

Setup score 47 out of 100
Latest Close 1.18 CAD 24 Jul 2026
1W Return -25.8% latest completed week
4W Return 7.3% short-term follow-through
12W Return 96.7% quarterly tape
Trend Breadth 9.6% 5 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 32.26% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -25.8% Latest completed week; four-week move 7.3%. Indicator stack 23/84 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 32.26% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 21 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 57.6% above the Trend Line and sits at 44.8% of its 52-week range. The latest completed week returned -25.8%, after a 7.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4012-week average 0.15

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.40Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.3% over four weeks, 96.7% over 12 weeks, and 49.4% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-25.8%
4W7.3%
12W96.7%
26W68.6%
52W49.4%
Active trend streak5 weeks
Active weeks in one year5
Trend breadth9.6%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.36Latest activity-pressure read.
Pressure change114.9%Four-week change in activity pressure.
Leadership54.09Latest relative-leadership reading.
RS change1.0%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 64% Model confidence 52%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength63/100Blend of value, momentum, and quality. Underlying universe rank 38; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality57/100Profitability and accounting quality. Underlying universe rank 44; rank 1 is best.
Momentum57/100Medium-term price momentum. Underlying universe rank 44; rank 1 is best.
Growth58/100Revenue and earnings growth. Underlying universe rank 43; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
7.6%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
65.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-44.0%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-1.8%
Net share repurchases relative to market value.
Shareholder yield
-1.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 21 relevant articles.

1 positive · 19 neutral · 1 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.3%Distance below the 52-week high.
13-week volatility35.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher6 of 2610 weeks finished lower.
Best week+103.7%Week of 26 Jun.
Worst week-25.8%Week of 24 Jul.
Latest week-25.8%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains0
Flat weeks10
Modest losses2
Sharp losses8
Recent vol35.1%13-week weekly-return volatility.
Base vol25.4%52-week weekly-return volatility.
Up/down split14/20Count of positive and negative weeks in the 52-week window.
Average skew26.9% / -11.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape41/100

Trend, activity pressure, participation, and risk combine to a 41/100 tape read.

 Indicator analysis55/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 5/12.

Activity pressure 0.40; No reversal markers Next-Week ExpectancyNegative 32.26%

Next-week expectancy is negative with a 32.26% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors58/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 79 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment50/100

Weighted news tone is neutral across 21 relevant articles.

Press Release: Crown Capital Provides Bi-Weekly MCTO Default Status Report Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20261.18 CAD-25.8%0.75 CAD2.45 CAD1.3654.092.1KOn
17 Jul 20261.59 CAD-11.2%0.74 CAD2.49 CAD1.64109.10200On
10 Jul 20261.79 CAD-5.8%0.71 CAD2.53 CAD1.28138.097.3KOn
3 Jul 20261.90 CAD72.7%0.66 CAD2.57 CAD0.92157.6276.7KOn
26 Jun 20261.10 CAD103.7%0.61 CAD2.61 CAD0.6353.5769.8KOn
19 Jun 20260.54 CAD0.0%0.60 CAD2.65 CAD0.22-24.830Off
12 Jun 20260.54 CAD-6.9%0.60 CAD2.70 CAD0.38-26.120Off
5 Jun 20260.58 CAD9.4%0.60 CAD2.74 CAD0.62-20.870Off
29 May 20260.53 CAD-3.6%0.60 CAD2.79 CAD0.78-29.591.5KOff
22 May 20260.55 CAD-12.7%0.60 CAD2.84 CAD0.72-27.612.0KOff
15 May 20260.63 CAD0.0%0.60 CAD2.88 CAD0.54-16.880Off
8 May 20260.63 CAD5.0%0.60 CAD2.93 CAD0.19-18.606.0KOff
1 May 20260.60 CAD0.0%0.61 CAD2.97 CAD-0.18-23.310Off
24 Apr 20260.60 CAD0.0%0.60 CAD3.02 CAD-0.28-24.560Off
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.